Exagen
XGN
38 hedge funds and large institutions have $22.4M invested in Exagen in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
0.19% more ownership
Funds ownership: 34.65% → 34.84% (+0.19%)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
7% less funds holding
Funds holding: 41 → 38 (-3)
11% less capital invested
Capital invested by funds: $25.1M → $22.4M (-$2.66M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
73% less call options, than puts
Call options by funds: $18K | Put options by funds: $66K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$629K |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$418K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$342K |
| 4 |
MCM
Massar Capital Management
Stamford,
Connecticut
|
+$78.7K |
| 5 |
PWM
Palumbo Wealth Management
Great Neck,
New York
|
+$47.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$586K |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$176K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$146K |
| 4 |
Renaissance Technologies
New York
|
-$70.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$68.2K |
XGN Hedge Fund Activity: Q1 2025 in Review
38 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q1 2025, worth a combined $22.4M — down 11% from $25.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of XGN and 4 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 10 added.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $629K. The largest seller was Stonepine Capital Management, cutting an estimated $586K.
- 38 institutional investors held Exagen (XGN) as of Q1 2025, down from 41 in Q4 2024.
- Funds reported $22.4M of Exagen stock for Q1 2025, down 11% quarter-over-quarter.
- 4 funds opened new Exagen positions in Q1 2025 and 7 closed out, a net change of -3 holders.
- The largest Exagen buyer in Q1 2025 was Hudson Bay Capital Management, an estimated $629K added.
- The largest Exagen seller in Q1 2025 was Stonepine Capital Management, an estimated $586K sold.
Based on aggregated 13F filings for Q1 2025.